Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human insulin regimens in hormonal disease
2022-000297-26Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human insulin, insulin lispro and insulin aspart in diabetes mellitus (DM), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2022; status: completed.
02
Drugs
human insulininsulin lisproinsulin aspart
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on 2022-000297-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000297-26.